Experimental groups | Experimental treatments |
---|---|
Sham | Intracerebral cannula + electrocoagulation of the vertebral arteries + PBS (total 7.5 μl) |
I/R | Intracerebral cannula + electrocoagulation of the vertebral arteries + carotid artery occlusion + PBS (total 7.5 μl) |
DADLE | Intracerebral cannula + electrocoagulation of the vertebral arteries + carotid artery occlusion + 2.5 nmol DADLE (total 7.5 μl) |
DADLE + naltrindole | Intracerebral cannula + electrocoagulation of the vertebral arteries + carotid artery occlusion + 2.5 nmol DADLE + 2.5 nmol naltrindole (total 7.5 μl) |
DADLE + 3-MA | Intracerebral cannula + electrocoagulation of the vertebral arteries + carotid artery occlusion + 2.5 nmol DADLE + 600 nmol 3-MA (total 7.5 μl) |
DADLE + compound C | Intracerebral cannula + electrocoagulation of the vertebral arteries + carotid artery occlusion + 2.5 nmol DADLE + 100 nmol compound C (total 7.5 μl) |
A769662 | Intracerebral cannula + electrocoagulation of the vertebral arteries + carotid artery occlusion + 100 nmol A769662 (total 7.5 μl) |
Compound C | Intracerebral cannula + electrocoagulation of the vertebral arteries + carotid artery occlusion + 100 nmol compound C (total 7.5 μl) |